Loading clinical trials...
Loading clinical trials...
Distribution and Clinical Implication of Coronary Flow Reserve and Index of Microcirculatory Resistance in Patients With Heart Failure With Preserved Ejection Fraction Without Significant Coronary Artery Disease
Conditions
Interventions
Invasive physiologic evaluation (fractional flow reserve, coronary flow reserve, index of microcirculatory resistance)
Locations
1
South Korea
Samsung Medical Center
Seoul, South Korea
Start Date
January 25, 2021
Primary Completion Date
September 30, 2024
Completion Date
December 31, 2024
Last Updated
January 30, 2024
NCT07083011
NCT07037459
NCT07057466
NCT07093528
NCT07219511
NCT07272902
Lead Sponsor
Samsung Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions